Led by Professor Keith Channon, RDM is one of 16 departments within the Medical Sciences Division. RDM was formed in 2012 to enhance further the interfaces between clinical and basic science programmes, including those of the Weatherall Institute of Molecular Medicine and of the Oxford University Hospitals NHS Trust.
The department hosts internationally renowned programmes in a broad range of sciences related to medicine, ranging from cardiovascular, diabetes, endocrinology, and stroke research, to molecular medicine, immunology, haematology and pathology, including programmes in stem cell & regenerative medicine.
With research interests and expertise in translating molecular and cellular science across multiple disease areas, RDM’s remit spans basic research through to clinical application.
RDM is one of the largest departments in the University. We employ approximately 700 scientific and support staff across a range of disciplines. Our academics contribute to the teaching of 450 undergraduate medical students within the Clinical School, and supervise around 125 postgraduate research students. RDM has an annual turnover of £59M, of which over 80% is public and charitable external funding. RDM comprises 4 divisions:
- Division of Cardiovascular Medicine (CVM)
- Investigative Medicine Division (IMD)
- Nuffield Division of Clinical Laboratory Sciences (NDCLS)
- Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
A large number of researchers from IMD (MRC Translational Immune Discovery Unit) and NDCLS (MRC Molecular Haematology Unit) are based within the MRC Weatherall Institute of Molecular Medicine (MRC WIMM), which receives strategic support from the Medical Research Council.
RDM divisions benefit from a devolved administrative structure and each division is led by a Head of Division, with the support of a lead administrator or business manager. Collaboration across the RDM divisions is close and productive, with joint sponsorship of major projects and senior recruitment.